Bolding v. Astrazeneca Pharmaceuticals LP
Bolding v. Astrazeneca Pharmaceuticals LP is a federal product liability lawsuit filed on 04/23/2018 in the District Court, D. New Jersey. The case was terminated on 08/01/2018.
- Court
- District Court, D. New Jersey (D.N.J.)
Official Court Website → - Docket number
- 2:18-cv-08200
- Cause
- 28:1332 Diversity-Product Liability
28 U.S.C. § 1332 — Diversity jurisdiction - Nature of suit
- 367 Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability
Injury from a drug, medical device, or health-care product — often grouped into mass-tort litigation. - Jurisdiction
- Diversity
- Jury demand
- Plaintiff
- Date filed
- 04/23/2018
- Date terminated
- 08/01/2018
51,507 Product Liability cases in this court are indexed here.
Parties
- plaintiff · Bolding · 106 cases
- defendant · Astrazeneca Pharmaceuticals LP · 8379 cases
Part of a Larger Litigation Pattern
This is one of 8,380 Product Liability cases in our index naming ASTRAZENECA PHARMACEUTICALS LP — a possible mass-tort or coordinated-litigation cluster.
About Product Liability Lawsuits
Product liability lawsuits claim that a defective or dangerous product caused injury or harm. These often target manufacturers of drugs, medical devices, vehicles, or consumer goods, and are frequently grouped into mass-tort or multidistrict litigation when many people are affected by the same product.
Frequently Asked Questions
What is Bolding v. Astrazeneca Pharmaceuticals LP?
Bolding v. Astrazeneca Pharmaceuticals LP is a federal product liability lawsuit filed on 04/23/2018 in the District Court, D. New Jersey. The case was terminated on 08/01/2018. Product liability lawsuits claim that a defective or dangerous product caused injury or harm. These often target manufacturers of drugs, medical devices, vehicles, or consumer goods, and are frequently grouped into mass-tort or multidistrict litigation when many people are affected by the same product.
What type of case is this?
It is classified as “Product Liability” under the federal nature-of-suit system. Product liability lawsuits claim that a defective or dangerous product caused injury or harm. These often target manufacturers of drugs, medical devices, vehicles, or consumer goods, and are frequently grouped into mass-tort or multidistrict litigation when many people are affected by the same product.
What court is the case in?
The case is in the District Court, D. New Jersey, docket number 2:18-cv-08200.
When was the case filed?
Bolding v. Astrazeneca Pharmaceuticals LP was filed on 04/23/2018. It was terminated on 08/01/2018.
What law is the case brought under?
The docket lists the cause as 28 U.S.C. § 1332 — Diversity jurisdiction.
Other Cases Involving These Parties
Related Product Liability Cases
Source: public U.S. federal court record (docket 7569670).